recurrent endometrial cancer Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (2)
Any (1)

Phase 2 (1)
Phase 3 (1)
Unknown (1)

Interventional (2)
OBSERVATIONAL (1)

Alessandro Santin (1)
AstraZeneca (1)
Sun Yat-sen University (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadcancer

I am/have/hadmeasurable disease

I am/have/hadendometrial cancer

I am/have/hadneuropathy

I am/have/hadendometrial carcinoma

I am/have/hadcarcinoma

I am/have/hadrecurrent endometrial cancer

I am/have/hadct scan

I am/have/hadx-rays

I am/have/hadcarcinosarcoma

I am/have/hadcancer therapy

I am/have/hadnon-target

I am/have/hadhair thinning

I am/have/hadrenal function

I am/have/hadliver metastasis

I am/have/hadserum pregnancy test

I am/have/hadascites

I am/have/hadcarboplatin paclitaxel

I am/have/hadrecurrent disease

I am/have/hadmajor surgery

added new label for I am/have/had

I am looking for

I am looking forhormone therapy

I am looking foradjuvant

I am looking forcarboplatin

I am looking forplatinum-based chemotherapy

I am looking forcorticosteroids

I am looking forolaparib

I am looking forpaclitaxel

I am looking fordurvalumab

I am looking forprednisone

I am looking forsacituzumab govitecan

I am looking forimmunomodulators

I am looking forimmunomodulator

I am looking forendocrine therapy

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

recurrent endometrial cancer

cancer treatment

paclitaxel

adjuvant

carboplatin paclitaxel

0 views
19 Feb, 2024

A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.

renal function

major surgery

recurrent endometrial cancer

ct scan

imaging techniques

0 views
19 Feb, 2024

A Study to Explore Personalized Treatment for Patients with Recurrent Gynecological Malignancies Based on MTB (RWS-MTB)

This is a non-interventional, real-world study divided into two parts: a retrospective study and a prospective study.The main question it aims to answer is:Will genomic sequencing and molecular tumor boards lead to clinical responses in patients with recurrent ovarian, cervical, or endometrial cancer? The retrospective arm will analyze data from …

0 views
17 Jan, 2025